Understand the source comparison
Can You Stack ARA-290 Other Peptides: Protocol Comparison
ARA-290 + BPC-157 Cytoprotection + angiogenesis + collagen synthesis Separate by 6+ hours; different injection sites ARA-290: 4mg BID; BPC-157: 250–500mcg QD Strong (multiple tissue repair models) First-line stack for soft tissue injury and wound healing; comp
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- ARA-290 + BPC-157
- Cytoprotection + angiogenesis + collagen synthesis
- Separate by 6+ hours; different injection sites
- ARA-290: 4mg BID; BPC-157: 250–500mcg QD
- Strong (multiple tissue repair models)
- First-line stack for soft tissue injury and wound healing; complementary pathways with minimal overlap
- ARA-290 + TB-500
- Anti-apoptotic signaling + actin-mediated cell migration
- TB-500 2x weekly; ARA-290 daily (BID on TB-500 days)
- ARA-290: 4mg BID; TB-500: 2–5mg twice weekly
- Moderate (primarily tendon/ligament models)
- Best for structural tissue repair where scar reduction is priority; logistics-friendly dosing schedule
- ARA-290 + CJC-1295/Ipamorelin
- Tissue protection + GH/IGF-1 axis activation
- CJC/Ipa before bed; ARA-290 AM + mid-afternoon
- ARA-290: 4mg BID; CJC/Ipa: 100/100mcg QHS
- Moderate (indirect synergy via oxidative stress reduction)
- Systemic recovery stack; most effective during high training volume or caloric deficit
- ARA-290 + Collagen Peptides (oral)
- IRR activation + substrate availability for ECM synthesis
- ARA-290 injected; collagen oral (10–20g daily)
- ARA-290: 4mg BID; Collagen: 15g oral QD
- Weak (mechanistic plausibility, limited direct evidence)
- Low-risk addition; collagen provides raw material while ARA-290 protects synthesis pathways
- ARA-290 + Cerebrolysin
- Neuroprotection via distinct receptor systems (IRR vs neurotrophic factors)
- Separate by 8+ hours minimum
- ARA-290: 4mg BID; Cerebrolysin: 5–10ml IM 2–3x weekly
- Weak (theoretical synergy; limited combination studies)
- High potential for CNS injury models; requires careful monitoring due to overlapping anti-inflammatory effects